Summary
78 / 100 · Bulios Score
What speaks for it
- It earns 33 USD a year on every 100 USD of invested capital.
- It has raised its dividend 38 years in a row.
- It has no debt and holds $6.47M in cash.
- The share price is below the Bulios Fair Price.
What to watch
- Operating profit covers the interest on its debt only 1.3 times.
- Earnings per share fell by 6.0% a year over the last 3 years.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 26.1 USD for 1 USD of yearly profit. Over the last five years it was 27.0 USD on average.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 4.9% a year over 5 years. Over the last 3 years it grew by 3.1% a year. Earnings per share fell by 6.0% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 28 USD
- Sales and administration 35 USD
- Taxes and other 21 USD
- Net profit 16 USD
Net profit, industry median (REIT - Healthcare Facilities) 11 USD
Out of every 100 USD of revenue, 16 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesIt has no debt.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 7.90%
- Paid out of profit
- 206%
- Raised in a row
- 38 years
You receive $2.99 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Neutral- Buy 0
- Hold 1
- Sell 0
No analyst has published a price target.
0.0% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2022By product
- Product and Service, Other 100%
By region
The company reports no revenue by region.
Product and Service, Other brings in 100% of revenue.
Segments in detail